MRK

Merck & Co., Inc.

Tremor tracks 194 of its cancer trials. This is a large company with many drugs, so one trial matters less to it, and company-wide signals count for half.

Company-wide warning signs

These add points to every one of this company's trials.

5 insiders sold shares within a monthSince Aug 13, 2026+1.9

Trials

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

17 sales (17 not pre-planned) · 0 purchases

Guindo ChirfiEVP, Access, Policy & Comms · Aug 13, 2026Sold 10,000 sharesabout $1.4 million · not pre-planned
Zachary JenniferEVP, General Counsel · Aug 12, 2026Sold 80,315 sharesabout $10.7 million · not pre-planned
DeLuca Richard R.EVP&Pres, Merck Animal Heallth · Aug 12, 2026Sold 11,099 sharesabout $1.5 million · not pre-planned
DeLuca Richard R.EVP&Pres, Merck Animal Heallth · Aug 12, 2026Sold 600 sharesabout $79 thousand · not pre-planned
DeLuca Richard R.EVP&Pres, Merck Animal Heallth · Aug 11, 2026Sold 7,410 sharesabout $973 thousand · not pre-planned
DeLuca Richard R.

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.